|
Price and Volume
Detailed Quote
Compare to:
Components
View All
|
Top News
More News
Theravance to Present at Investor Conferences in June 2013
Today 16:05 EDT
Sentiment Drives MannKind to Fresh Highs Ahead of Vital Catalyst
Today 15:52 EDT
An enormous amount of hype in the last couple of weeks has sent the diabetes and cancer drug developer MannKind Corporation (NASDAQ: MNKD) soaring, particularly after the company’s first quarter... Read More
from Bio-Wire.Com
|